Delap Wealth Advisory, LLC Fibrogen Inc Transaction History
Delap Wealth Advisory, LLC
- $247 Billion
- Q1 2024
A detailed history of Delap Wealth Advisory, LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Delap Wealth Advisory, LLC holds 11,406 shares of FGEN stock, worth $11,976. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,406Holding current value
$11,976% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding FGEN
# of Institutions
119Shares Held
61.9MCall Options Held
1.54MPut Options Held
221K-
Primecap Management CO Pasadena, CA14.4MShares$15.1 Million0.03% of portfolio
-
Armistice Capital, LLC New York, NY7.94MShares$8.33 Million0.25% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$7.32 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.44MShares$6.76 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.5MShares$2.63 Million0.02% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $98.4M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...